Vir Biotechnology, Inc. · NASDAQ:VIR

Sabatini Brent received 50,000 Vir Biotechnology, Inc. shares as an award (Form 4)

Traded Nov 15, 2026 · Filed Nov 16, 2026

On Nov 15, 2026, Sabatini Brent (SVP, Chief Accounting Officer) received 50,000 Vir Biotechnology, Inc. shares as an award under a trading plan, leaving 111,902 shares. Filed Nov 16, 2026 (Form 4).

Awarded
50,000 shares
Holding after
111,902 shares
Trading plan
Yes (Made under a plan set in advance)
Role
SVP, Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 15, 2026Common StockAward50,000111,902Direct

Source

Download original · View original at SEC

Related